- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07934212
Acute Effects of L-Theanine and L-Tyrosine on Cognitive and Archery Performance (THEA-TYR)
Acute Effects of L-Theanine, L-Tyrosine, and Combined Supplementation on Cognitive and Archery Performance: A Randomized, Placebo-Controlled Crossover Study
This study aims to investigate the acute effects of L-theanine, L-tyrosine, and their combination on cognitive performance and archery performance in trained archers. The study will use a randomized, placebo-controlled, five-condition crossover design involving 21 healthy male archers aged 18 years or older.
Participants will complete five experimental conditions: placebo, L-theanine supplementation (6 mg/kg), L-tyrosine supplementation (50 mg/kg), combined L-theanine and L-tyrosine supplementation, and a no-supplement control condition. Supplements will be administered 60 minutes before performance assessments, with at least 72 hours between experimental sessions.
Cognitive performance will be assessed using the Stroop Test, while archery performance will be evaluated through indoor target shooting at 18 meters. Mood states and perceived exertion will also be assessed using the BRUMS questionnaire and Borg CR-10 scale, respectively.
The study will examine whether these supplementation conditions produce different acute responses in cognitive function and archery performance.
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- 1. Being 18 years of age or older. 2. Being a healthy male individual. 3. Having at least five years of regular archery experience. 4. Training in archery at least three days per week. 5. Having national or international competition experience in archery. 6. Voluntarily agreeing to participate in the study.
Exclusion Criteria:
-
1. Having a medical condition that may interfere with participation in the study.
2. Having a known allergy or hypersensitivity to L-theanine or L-tyrosine. 3. Using medications or supplements that may affect cognitive or physical performance during the study period.
4. Being unable to complete all five experimental sessions. 5. Failing to comply with the study procedures.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Five-Condition Crossover Group
All participants will complete five experimental conditions in a randomized crossover design: placebo, L-theanine, L-tyrosine, combined L-theanine and L-tyrosine, and no-supplement control. Each participant will receive all five conditions, with at least 72 hours of washout between sessions. |
Participants will receive a placebo 60 minutes before performance assessments. The placebo will be prepared in a form identical to the active supplementation capsules to maintain blinding. Participants will receive L-theanine at a dose of 6 mg/kg body weight, administered 60 minutes before performance assessments. Participants will receive L-tyrosine at a dose of 50 mg/kg body weight, administered 60 minutes before performance assessments. Participants will receive a combination of L-theanine (6 mg/kg body weight) and L-tyrosine (50 mg/kg body weight), administered together 60 minutes before performance assessments. Participants will complete the performance assessments without receiving any supplementation during this condition. This condition will serve as the no-supplement control for comparison with the placebo and active supplementation conditions. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Total Archery Shooting Score
Periodo de tiempo: Immediately after the archery shooting task in each experimental session (approximately 60 minutes after supplement or placebo administration).
|
Archery performance will be assessed by recording the total score obtained from 15 arrows (5 sets of 3 arrows) shot at an indoor target from a distance of 18 meters using a 40-cm target face. Higher scores indicate better archery performance. |
Immediately after the archery shooting task in each experimental session (approximately 60 minutes after supplement or placebo administration).
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- INU-ARCH-2026-01
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .